QUANTUM GENOM NR Share Price Euronext Paris
Equities
FR0010783837
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- EUR | - |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 74.87L 80.76L 67Cr |
---|---|---|---|---|---|
Net income 2024 * | -30L -32.36L -27Cr | Net income 2025 * | - | EV / Sales 2024 * | - |
Net cash position 2024 * | 87L 93.84L 78Cr | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.19
x | P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.23% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | - | |
Lionel Ségard
FOU | Founder | 56 | 23/05/23 |
Benoît Gueugnon
DFI | Director of Finance/CFO | - | 01/18/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lionel Ségard
FOU | Founder | 56 | 23/05/23 |
François Pelen
BRD | Director/Board Member | 67 | - |
Chief Executive Officer | 63 | - |
1st Jan change | Capi. | |
---|---|---|
+16.59% | 4.44TCr | |
-10.62% | 3.77TCr | |
+40.49% | 3.98TCr | |
+29.92% | 3.15TCr | |
-9.78% | 2.7TCr | |
+12.34% | 2.63TCr | |
+41.53% | 1.38TCr | |
+31.49% | 1.25TCr | |
-7.40% | 1.13TCr |